Product Information
GVOKE PFS 1-PK 1 MG/0.2 ML SYR is a brand product labeled by Xeris Pharmaceuticals, Inc., priced at $1600.9577 per ML under NDC 72065013111. Its NADAC has been published 319 times since May 20, 2020.
Strength
1 mg/.2mL
Manufacturer
Xeris Pharmaceuticals, Inc.NDC
72065013111
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
GLUCAGONApproval Type
New Drug (NDA)
FDA Application
NDA212097On Market Since
9/10/2019
Pharmacological Classes
Price Statistics
The NADAC for GVOKE PFS 1-PK 1 MG/0.2 ML SYR has been published 319 times since May 20, 2020, and over the history we have for it it has risen 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1600.9577 per ML |
|---|---|
| All-time high | $1604.3171 (Jun 10, 2026) |
| All-time low | $1340.0286 (May 20, 2020) |
| 52-week high | $1604.3171 |
| 52-week low | $1557.3479 |
| Median price | $1468.9945 |
| Average price | $1460.7307 |
| Largest weekly change | +3.0% (Feb 15, 2023) |
| Weeks tracked | 319 |
| Tracking since | May 20, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GVOKE PFS 1-PK 1 MG/0.2 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for GVOKE PFS 1-PK 1 MG/0.2 ML SYR, manufactured by Xeris Pharmaceuticals, Inc., is $1600.9577 per ML (NDC 72065013111), effective Jun 24, 2026.
How has the price of GVOKE PFS 1-PK 1 MG/0.2 ML SYR changed over time?
Over the history we have for it, the NADAC for GVOKE PFS 1-PK 1 MG/0.2 ML SYR has risen 19.5%. It has been tracked across 319 weekly CMS publications since May 20, 2020.
What are the highest and lowest recorded NADAC prices for GVOKE PFS 1-PK 1 MG/0.2 ML SYR?
Since May 20, 2020, the NADAC for GVOKE PFS 1-PK 1 MG/0.2 ML SYR has ranged from a low of $1340.0286 (May 20, 2020) to a high of $1604.3171 (Jun 10, 2026), with a median of $1468.9945 per ML.
Are there cheaper alternatives to GVOKE PFS 1-PK 1 MG/0.2 ML SYR?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, GVOKE HYPOPEN 2-PK 1 MG/0.2 ML, is $1597.9517 per ML — about 0% below GVOKE PFS 1-PK 1 MG/0.2 ML SYR.
Who manufactures GVOKE PFS 1-PK 1 MG/0.2 ML SYR?
GVOKE PFS 1-PK 1 MG/0.2 ML SYR (NDC 72065013111) is labeled by Xeris Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification